ADVERTISEMENT

Francesca Palandri, MD, PhD

Francesca Palandri, MD, PhD

Q&As

Evaluating the Correlation Between Anemia and Blast Phase Evolution Risk Among Patients With Myelofibrosis

02/21/2024

Francesca Palandri , MD, PhD;

Francesca Palandri, MD, PhD, evaluates the correlation between anemia and an increased risk of evolution into blast phase for patients with ruxolitinib-treated myelofibrosis.

Francesca Palandri, MD, PhD, evaluates the correlation between anemia and an increased risk of evolution into blast phase for patients with ruxolitinib-treated myelofibrosis.

Francesca Palandri, MD, PhD,...

02/21/2024

Oncology

Francesca Palandri, MD, PhD

Q&As

Encouraging Developments in Treatment Strategy for Patients With Myelofibrosis

02/21/2024

Francesca Palandri , MD, PhD;

Francesca Palandri, MD, PhD, discusses future possibilities and new breakthroughs in treatment strategies for patients with myelofibrosis, such as expanding treatment options for high-risk patients and more deeply considering the biology of...

Francesca Palandri, MD, PhD, discusses future possibilities and new breakthroughs in treatment strategies for patients with myelofibrosis, such as expanding treatment options for high-risk patients and more deeply considering the biology of...

Francesca Palandri, MD, PhD,...

02/21/2024

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement